CIK 0000034956
- Non-accelerated filer
- Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262593535
- Phone
- +1 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $4,770,520
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$4,770,520. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | STAAB THOMAS R II Chief Financial Officer | Purchase | +5,675 | $1.94 | $11K | 15,675 |
| 2026-05-11 | STAAB THOMAS R II Chief Financial Officer | Grant or award | +10,000 | 10,000 | ||
| 2026-05-11 | STAAB THOMAS R II Chief Financial Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 |
Page 1 of 1 · 3 trades